Full-year 2025 net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) full year 2025 net product revenue of $587 millionEMPAVELI® ...
Weight loss injections which can be prescribed by the NHS are: semaglutide, marketed under the brand name Wegovy tirzepatide, sold as Mounjaro liraglutide, sold as Saxenda They are given as weekly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results